Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
1.
Med Trop Sante Int ; 1(1)2021 03 31.
Article in French | MEDLINE | ID: mdl-35586643

ABSTRACT

Objective: In sub-Saharan Africa where 90% of malaria cases are concentrated, the control of this disease constitutes a major challenge whose diagnosis by thick and thin smear deserves to be exact and reproducible. The purpose of this study is to assess the performance of thick/thin blood smear in order to improve its implementation process. Material and methods: This was a descriptive and analytical study that took place from May to June 2017 and involved participating laboratories (PL) coming from public, liberal and confessional sectors in Lomé. A set of 13 blood smear slides of variable parasite densities (PD) with assigned values (AV) of parasite densities and the Plasmodium species assigned was used. The criterion for establishing the parasite densities compliance interval was assigned values ± 25% and the performance rates were compared to the 80% recommended by the WHO for Africa region. Results: 41.9% (13/31) of the PLs had a compliance rate greater than 80% including four with a performance of 100% for the ability to identify the Plasmodium species. For the parasitaemia < 100/µl, 51.6% of participating laboratories had a performance rate less than 80% and for parasitaemia > 2000/µl, 100% of these laboratories had a performance rate greater than 80%. Conclusion: The evaluated laboratories had insufficient ability for the identification of Plasmodium falciparum and the correct estimation of low parasitaemia. A need to strength the technical skills, adapted to the context of low parasitaemia are essential to improve the biological diagnosis of malaria in Togo.


Subject(s)
Malaria , Plasmodium , Humans , Malaria/diagnosis , Microscopy , Parasitemia/diagnosis , Plasmodium falciparum , Togo/epidemiology
2.
Bull Soc Pathol Exot ; 108(3): 181-7, 2015 Aug.
Article in French | MEDLINE | ID: mdl-25476256

ABSTRACT

The aim of this study is to verify the level of transmission of lymphatic filariasis three years after stopping mass drug treatment in the 7 endemic districts in Togo. The survey was conducted in 2012 in Togo's 7 endemic districts grouped into four evaluation units (EU) using the WHO-recommended transmission assessment survey (TAS) protocol. Children aged 6-7 years were screened for Wuchereria bancofti antigen using the immunochromatographic card (ICT) method. A cluster sampling method was used to select eligible children in schools as the net primary-school enrolment ratio is greater than or equal to 75% in each of the four EUs. The number of children and schools to be selected in each EU, the randomization list for the selection of these children and the critical cut-off number of positive cases not to exceed were automatically generated using the Survey Sample Builder (SSB) tool, (NTD Support Center, Atlanta, Ga, USA). For confirmation, positive cases were subsequently tested for microfilaremia using nocturnal thick blood smear and for filarial antigen using Og4C3 antigen ELISA (TropBio ELISA Kit®, Townsville, Queensland, Australia). An EU is considered to have passed the test successfully (it is assumed that transmission can no longer be sustained), when the number of positive cases is below the critical cut-off number set by the SSB, which is roughly equivalent to 2% prevalence. Of the 1 706 children surveyed in Kpendjal-Tone's EU, 1 549 in Binah-Doufelgou's EU, 1 550 in Kozah's EU and the 1 575 in Amou-Haho's EU, 8 (0.46%), 1 (0.08%), 0 (0.00%) and 4 (0.25%) ICT positive cases respectively were detected. The number of positive ICT tests was well below 18, the critical cut number for each of the 4 EUs. All 13 ICT positive cases tested negative for nocturnal microfilaremia and Og4C3 ELISA. We conclude that all four EU passed the TAS with success, and the transmission of Wuchereria bancrofti is no longer likely to be sustained in the 7 endemic districts in Togo 3 years after stopping the MDA. A new TAS will be carried out in 2015, after which, if the results are still good, the country will submit a dossier to WHO for verification of the elimination of lymphatic filariasis.


Subject(s)
Albendazole/therapeutic use , Anthelmintics/therapeutic use , Elephantiasis, Filarial/epidemiology , Endemic Diseases , Government Programs , Health Promotion , Ivermectin/therapeutic use , Albendazole/administration & dosage , Animals , Anthelmintics/administration & dosage , Antigens, Helminth/blood , Child , Chromatography, Affinity/instrumentation , Cross-Sectional Studies , Elephantiasis, Filarial/diagnosis , Elephantiasis, Filarial/prevention & control , Elephantiasis, Filarial/transmission , Endemic Diseases/prevention & control , Female , Health Promotion/organization & administration , Health Surveys , Humans , Ivermectin/administration & dosage , Male , Mass Screening , Microfilariae/isolation & purification , Parasitemia/diagnosis , Parasitemia/parasitology , Practice Guidelines as Topic , Program Evaluation , Sampling Studies , School Health Services , Schools , Togo/epidemiology , World Health Organization , Wuchereria bancrofti/immunology , Wuchereria bancrofti/isolation & purification
3.
Med Sante Trop ; 24(3): 266-70, 2014.
Article in French | MEDLINE | ID: mdl-24922616

ABSTRACT

To assess the hepatitis B virus (HBV) serologic status of hospital health care personnel in Lome. From June 1 to August 31, 2007, 100 workers vaccinated against HBV and 50 unvaccinated workers participated in this comparative cross-sectional study. The data studied were: age, sex, vaccination status, history of accidental exposure to blood, and enzyme-linked immunoassay results for HBs antigen (Ag), total anti-HBc antibodies (Ab), and anti-HBs Ab. Vaccinated subjects had a mean age of 33.2 ± 8.2 years and unvaccinated subjects of 35.2 ± 9.6 years; their respective sex ratios (M:W) were 2:1 and 3:1. Protective levels (>10 IU/L) of anti-HBs Ab were found in 78% (n = 78) of vaccinated subjects compared with 44% (n = 22) of those unvaccinated. HBs Ag was found in 36% (n = 36) of vaccinated and 56% (n = 28) of unvaccinated subjects. Of subjects previously accidentally exposed to blood, 67% (n = 35) had HBs Ag compared with 30% (n = 29) of those subjects without such exposure. This study has proved the high prevalence of HBs Ag carrier status among health care workers in Lome and confirms the importance of vaccination against HBV.


Subject(s)
Carrier State/diagnosis , Hepatitis B Antibodies/blood , Hepatitis B Vaccines , Hepatitis B virus/immunology , Personnel, Hospital , Adult , Cross-Sectional Studies , Female , Humans , Male , Togo , Vaccination
4.
Med Sante Trop ; 23(4): 412-6, 2013.
Article in French | MEDLINE | ID: mdl-24480599

ABSTRACT

Rational use of the artemisinin-based combination therapies in Togo requires laboratory parasitemia values to confirm suspected malaria. This study was conducted to determine the impact of the measured white blood cell (WBC) count on the determination of malaria parasite density among children younger than 5 years old infected with uncomplicated Plasmodium falciparum in Togo. This cross-sectional study of 267 children from four pediatric centers diagnosed malaria with both thick and thin blood smears and counted WBCs with a hematology analyzer. The parasite densities, calculated with the number of WBCs and estimated with an assumed count of 8,000/µL, were compared with the Wilcoxon matched pairs signed-rank test. The children's median age was 35 months (interquartile range [24-48]), with a sex ratio of 1.32. The median WBC value was 8,300 cells/µL (range: 1,300-24,900 cells/µL). The median parasitemia value calculated with the absolute WBC count was 35,714 (range: 139-48,860 parasites/µL) was not statistically different from that estimated with the assumed value of 8,000 cells/µL - 33 125 parasites/µL (p = 0.564). This study shows that malaria parasite density obtained by assuming 8000 cells/µL does not result in overestimations for children aged 6-59 months.


Subject(s)
Malaria, Falciparum/blood , Malaria, Falciparum/parasitology , Parasitemia/blood , Parasitemia/parasitology , Plasmodium falciparum , Child, Preschool , Cross-Sectional Studies , Female , Humans , Infant , Leukocyte Count , Male , Togo
5.
Med Sante Trop ; 22(3): 307-11, 2012.
Article in French | MEDLINE | ID: mdl-23174189

ABSTRACT

BACKGROUND: Chronic myeloid leukemia (CML) is a clonal malignant myeloproliferative disorder characterized by the expansion of hematopoietic cells carrying the Philadelphia chromosome (t 9.22). Our main objective was to assess the efficacy of imatinib in CML patients, measured by their survival. METHODS: Over a six-year period (June 2003 through May 2009), 25 patients were seen regularly for CML at the Lomé Campus teaching hospital. Patients received imatinib after diagnosis and underwent regular laboratory monitoring (quantification of BCR-ABL ratio by RT-PCR). Patients' survival and treatment response were evaluated. RESULTS: Patients' mean age at diagnosis was 40 years (range: 9 to 72 years). Men predominated (17 compared with 7 women). Splenomegaly was found in 80% of cases. The mean leukocyte level was 188.71 g/L (24.4-350). Six patients (24%) had thrombocytosis with a mean platelet count of 491.15 g/L (108-2000). Six patients (24%) died after developing accelerated-phase CML or blast crisis. Estimated overall survival of patients at 6 years was 60%. Molecular biology monitoring detected a secondary G250E mutation with resistance to imatinib in one patient. Standard hematological side effects led to reduction in imatinib doses. The principal nonhematological side effects were weight gain and transient digestible disorders. CONCLUSIONS: At six years after diagnosis, imatinib was effective in treating patients with CML, even in sub-Saharan Africa. Mutation-induced resistance required regular molecular biological monitoring to determine the need to switch to later-generation tyrosine kinase inhibitors.


Subject(s)
Antineoplastic Agents/therapeutic use , Benzamides/therapeutic use , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy , Piperazines/therapeutic use , Pyrimidines/therapeutic use , Adolescent , Adult , Aged , Child , Female , Humans , Imatinib Mesylate , Male , Middle Aged , Prospective Studies , Togo , Young Adult
6.
Trop Med Int Health ; 17(7): 896-903, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22594642

ABSTRACT

OBJECTIVE: To conduct a nationwide integrated neglected tropical disease (NTD) prevalence survey to define the need for public health interventions using an innovative mapping protocol. METHODS: Two villages were selected in every peripheral health unit in endemic districts: 29 districts for schistosomiasis and STH, 15 of them for trachoma. In each village, 15 children aged 6-9 years at a randomly selected school were tested. An additional convenience sample of 35 children aged 1-5 years underwent an eye examination for trachoma. This integrated mapping was followed by a 20-cluster trachoma survey in each district that surpassed the WHO-defined threshold of 10% prevalence of trachomatous inflammation-follicular (TF). RESULTS: A total of 1096 villages were surveyed in <6 weeks. The district prevalence of schistosomiasis ranged from 2 to 49% and of STH from 5 to 70%, with prevalence at the village level ranging from 0 to 100% for both diseases. Two districts passed the threshold of 10% for active trachoma, but the cluster survey indicated this was because of misclassification bias and that the real prevalence was <1%. CONCLUSION: Results of this mapping were used by the MoH and partners to plan integrated mass drug administration (MDA). Mass drug administration for trachoma was not implemented as no district passed the threshold requiring public health intervention.


Subject(s)
Health Policy , Neglected Diseases/epidemiology , Public Health/methods , Schistosomiasis/epidemiology , Trachoma/epidemiology , Child , Child, Preschool , Humans , Infant , Neglected Diseases/prevention & control , Neglected Diseases/therapy , Prevalence , Schistosomiasis/prevention & control , Schistosomiasis/therapy , Togo/epidemiology , Trachoma/prevention & control , Trachoma/therapy
7.
Rev Neurol (Paris) ; 166(6-7): 648-52, 2010.
Article in French | MEDLINE | ID: mdl-20171707

ABSTRACT

UNLABELLED: Morbidity and mortality are high in children with refractory status epilepticus (RSE). Here, we assess the efficacy of midazolam for RSE in children. METHODS: This was a retrospective analysis of 29 children admitted to the Lille University Hospital pediatric intensive care unit (PICU) for RSE between May 2006 and July 2008. The onset of the study corresponded with a new therapeutic protocol applied in the PICU for RSE where midazolam was proposed as the first-line treatment (bolus ten continuous infusion until control) to be replaced by thiopenthal in case of failure. RESULTS: We recorded 29 patients with RSE during the study period: 26 were treated with midazolam, including two where midazolam replaced thiopenthal because of hypotension. Midazolam successfully controlled RSE in 58% of patients. Mean delay to cessation of RSE was 48+/-65 minutes. Hypotension was observed in 8% of midazolam-treated patients and 71% of thiopenthal-treated patients. Overall mortality was 15% (4/26). Two deaths occurred long after the cessation of RSE. None of the deaths occurred in midazolam-treated patients. CONCLUSION: Midazolam is an efficient treatment for RSE in children. Morbidity and mortality appear to be lower with midazolam compared with other antiepileptic drugs used for the treatment of RSE.


Subject(s)
GABA Modulators/therapeutic use , Midazolam/therapeutic use , Status Epilepticus/drug therapy , Adolescent , Catecholamines/blood , Child , Child, Preschool , Female , GABA Modulators/adverse effects , Humans , Hypotension/chemically induced , Infant , Male , Midazolam/adverse effects , Patient Acceptance of Health Care , Retrospective Studies , Thiopental/therapeutic use
9.
Med Trop (Mars) ; 68(6): 621-4, 2008 Dec.
Article in French | MEDLINE | ID: mdl-19639832

ABSTRACT

UNLABELLED: The hepatitis B surface antigen (HBsAg) is the only marker used for diagnosis and follow-up of hepatitis B infection in Togo. The purpose of this study was to evaluate the use of HBsAg testing for follow-up of hepatitis B infection. This study was conducted in 230 patients referred to the National Institute of Hygiene for HBsAg testing. In all cases the requested test was performed and the request and results were evaluated. RESULTS: The study group included 159 women (69%) and 71 men (31%). The overall prevalence of HBsAg was 10.87%. Prevalence was higher in men than in women. Highest prevalence rates were observed in the age groups 20 to 50, which corresponds to the peak period of sexual activity. The indication for testing was often not clearly specified by Laboratory engineers (85.71%), Clinical officers (73.68%) and physicians (61.24%). When mentioned, the indication was suspicion of hepatitis B (20.87%), work-up for pregnancy (8.70%), testing prior to vaccination (8.26%) and surveillance of an infected patient (1.30%). The prevalence of HBsAg was 0.00% in prevaccination tests, 5% in pregnancy workup tests, and 10.42% in hepatitis B suspicion tests. Test results were negative in one infected patient referred for follow-up. None of the patients with positive results returned for therapeutic follow-up testing and no marker other than HBsAg was requested regardless the indication. CONCLUSION: the laboratory of serology is under-used for hepatitis B surveillance. Hepatitis B follow-up using antigen HBsAg alone is inadequate and the equipment required for testing other markers is the same.


Subject(s)
Hepatitis B Surface Antigens/blood , Hepatitis B/immunology , Adolescent , Adult , Age Distribution , Biomarkers/blood , Child , Female , Humans , Male , Middle Aged , Population Surveillance , Prevalence , Sex Distribution , Togo , Young Adult
10.
Arch Pediatr ; 10(5): 410-6, 2003 May.
Article in French | MEDLINE | ID: mdl-12878333

ABSTRACT

UNLABELLED: Short-Stay Observation Units (SSOUs) in paediatric emergency departments are effective in reducing inpatient admissions but can also generate excessive short-stay hospitalisations. The aim of the study was to evaluate both these consequences and the different missions of SSOUs. METHODS: This prospective study included all children admitted in a 10-bed-medico-surgical SSOU of a tertiary-care paediatric emergency department from September 4, to October 31, 2001. At the time of SSOU admission, the physician indicated the purpose of the admission and which decision he would have made in the absence of a SSOU. RESULTS: Five hundred and nine children (median age = 4 years, chronic disease: 26%, trauma: 34%) were included, accounting for 15% of admissions. The mean length of stay was 14 +/- 8h. The decision in the absence of a SSOU would have been: inpatient hospitalization (77%), transfer to another hospital in the absence of inpatient room vacancy (7%), discharge home (10%), prolonged waiting in the emergency ward (4%), do not know or not indicated (2%). The SSOU admission was deemed appropriate in 81%: discharge home within 24h was likely in 65% and the final orientation of the child was uncertain in 16%. The admission was debatable in 13% and inappropriate in 6%. Sixty six per cent of children were discharged home. CONCLUSION: The SSOU reduced inpatient hospitalisations, generated few inappropriate short stay hospitalisations, and seemed particularly efficient for paediatric diseases. Proposed indicators should allow inter-hospital comparisons.


Subject(s)
Emergency Service, Hospital/organization & administration , Hospital Departments/organization & administration , Length of Stay , Pediatrics/organization & administration , Analysis of Variance , Chi-Square Distribution , Child, Preschool , Chronic Disease , Emergency Service, Hospital/statistics & numerical data , France/epidemiology , Hospital Departments/statistics & numerical data , Hospitalization/statistics & numerical data , Humans , Infant , Length of Stay/statistics & numerical data , Organizational Objectives , Patient Admission/statistics & numerical data , Patient Discharge/statistics & numerical data , Patient Transfer/statistics & numerical data , Pediatrics/statistics & numerical data , Prospective Studies , Time Factors , Wounds and Injuries/epidemiology
11.
Intensive Care Med ; 29(2): 329-31, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12594596

ABSTRACT

OBJECTIVE: To report two children admitted to our emergency department with respiratory failure, one for status asthmaticus with pneumomediastinum and requiring mechanical ventilation and the other for high suspicion of foreign body aspiration. INTERVENTIONS: Bronchoscopy revealed obstructive plugs and permitted their extraction and their identification as bronchial casts after the immersion in normal saline. Allergy was suspected in the first one, and Hemophilus influenzae infection was present in the second. The outcome was favorable. CONCLUSIONS: Plastic bronchitis is an infrequent cause of acute life-threatening respiratory failure that can mimic foreign body aspiration or status asthmaticus. Bronchoscopic extraction must be performed urgently in the case of severe obstruction. This entity is probably underestimated as the casts with their specific ramifications are difficult to recognize. We recommend the immersion in normal saline of all plugs discovered in children with predisposing diseases mainly represented by infections, allergy, acute chest syndrome, and congenital cardiopathies.


Subject(s)
Airway Obstruction/diagnosis , Bronchitis/diagnosis , Critical Care/methods , Mucus , Acute Disease , Airway Obstruction/complications , Airway Obstruction/therapy , Bronchi , Bronchitis/complications , Bronchitis/therapy , Bronchoscopy/methods , Causality , Child, Preschool , Diagnosis, Differential , Female , Foreign Bodies/complications , Foreign Bodies/diagnosis , Haemophilus Infections/complications , Haemophilus influenzae , Humans , Hypersensitivity/complications , Inhalation , Mediastinal Emphysema/etiology , Respiration, Artificial , Respiratory Insufficiency/etiology , Status Asthmaticus/etiology
13.
Rev Mal Respir ; 19(1): 53-61, 2002 Feb.
Article in French | MEDLINE | ID: mdl-17546814

ABSTRACT

UNLABELLED: Simple clinical markers have poor sensitivity; specificity and predictive value in both infants and adults when predicting the success of weaning from mechanical ventilation. Recently, multi-parametric indices, such as the CROP (Compliance-Respiratory Rate-Oxygenation-Pressure) and the RSB (Rapid-Shallow-Breathing) have been used in adults and subsequently in children. The aim of this study was to test the value of the pediatric CROP and RSB (CROPp, RSBp) and the accuracy of a simplified pediatric CROP (CROPpS) that does not require an arterial blood gas sample. MATERIALS AND METHODS: This prospective study was conducted in a pediatric ICU which does not admit neonates. All infants were intubated and ventilated at the time of entry. Spontaneous tidal volume and maximal negative inspiratory pressure, that are required to assess and calculate the indices, were measured using a Fleish pneumotachograph and a unidirectional valve. The other parameters were recorded or calculated. A maximum 4 hour-duration trial of spontaneous ventilation was then performed. Weaning failure was defined as the requirement of re-ventilation within 48 hours of extubation. The discriminant power of CROPp and RSBp was determined by calculating the area under the receiver operating characteristic (ROC) curve. The best cut-off value of the CROPpS was determined by chi2 optimisation. RESULTS: 39 children (20 males) were included in the trial. They had a median age of 3.2 years and a median duration of mechanical ventilation of 1.3 days. 89.7% of children were successfully weaned of mechanical ventilation. Sensitivity of CROP, and RSB, was 97% and 94%, specificity was 0% and 0%, positive predictive value was 89% and 89%, and negative predictive value was 0% and 0% respectively; the area under the ROC curve was 0.57 and 0.74. The CROP,S was found to be as accurate as the CROP, index using the same cut-off value. Comparison of the 2 groups (success, failure) revealed a significant difference in duration of ventilation (longer in the failure group). CONCLUSION: Even though they correctly classified 87% and 85% of patients respectively, the CROPp and RSBp are not good predictors of weaning from mechanical ventilation as the area under the ROC curve is less than 0.80. Other indices need to be evaluated.


Subject(s)
Severity of Illness Index , Ventilator Weaning , Child, Preschool , Female , Humans , Intensive Care Units, Pediatric , Male , Prospective Studies , Respiratory Function Tests , Respiratory Insufficiency/therapy
14.
Arch Pediatr ; 9(12): 1260-3, 2002 Dec.
Article in French | MEDLINE | ID: mdl-12536109

ABSTRACT

INTRODUCTION: Severe falciparum malaria is a polymorphous life-threatening disease. Hyperparasitemia is rare among non-immune children returning from tropical areas. CARE REPORT: We report a case of an infant returning from Ivory Coast who presented with fever, prostration and marked thrombocytopenia (22,000 platelets/mm(3)). Blood slide showed Plasmodium falciparum ring forms. Parasite density dramatically increased from 1.7% to 45%, and the child developed several features of severe malaria, according to WHO definition. CONCLUSION: In this non-immune infant, prostration and thrombopocytopenia seemed to be earlier predictors of severity than hyperparasitemia and other WHO criteria, which have not been yet validated in travelling children.


Subject(s)
Malaria, Falciparum/parasitology , Parasitemia/parasitology , Plasmodium falciparum/isolation & purification , Animals , Antimalarials/therapeutic use , Humans , Infant , Malaria, Falciparum/complications , Malaria, Falciparum/drug therapy , Male , Parasitemia/drug therapy , Quinine/therapeutic use , Seizures, Febrile/parasitology , Thrombocytopenia/parasitology , Travel , Treatment Outcome
15.
Arch Pediatr ; 8 Suppl 4: 677s-688s, 2001 Sep.
Article in French | MEDLINE | ID: mdl-11582913

ABSTRACT

In France, the incidence of meningococcal infections is increasing. The most severe presentation, called purpura fulminans, has a death rate of 20-25%; 5 to 20% of the survivors need skin grafts and/or amputations. Diagnosis of invasive meningococcal infection is very difficult when purpura and "toxic" appearance are absent: one should take into account parents' impression of their ill child. This diagnosis must be evoked in any child presenting with febrile purpura (like in the United Kingdom, parents should be encouraged to use the "tumbler test" to identify a vasculitic rash); a fulminant form is to be suspected in the presence of only one ecchymosis and signs of infection, remembering that recognition of shock is difficult in children. Recently, the Health Authority has recommended to administer a third generation cephalosporin promptly (before biological investigations) for any child with signs of infection and a necrotic or ecchymotic purpura (> 3 mm of diameter), and then to refer the patient to the hospital. By grouping the patients from 7 studies, it can be observed that preadmission antibiotic administration has a protective effect on mortality (odds ratio: 0.36; 95% confidence interval: 0.23-0.56); a negative effect was observed in only one of these series. Children with purpura fulminans should be referred to a paediatric intensive care unit. Management includes antibiotics, steroids, fluid resuscitation and catecholamines (be aware of hypoglycaemia, particularly in infants, and hypocalcaemia). Treatment of cutaneous necrosis and distal ischemia is difficult and still controversial: antithrombin, protein C, tissue plasminogen activator and vasodilator infusion have no proven efficacy. Cases must be rapidly notified to the Public Health Service who will institute chemoprophylaxis for close contacts. Given the predominance of serogroup B in France, we hope that an efficient vaccine will soon become available.


Subject(s)
IgA Vasculitis/drug therapy , Meningococcal Infections/drug therapy , Anti-Bacterial Agents/therapeutic use , Child , Child, Preschool , Diagnosis, Differential , Humans , IgA Vasculitis/diagnosis , Infant , Infant, Newborn , Intensive Care Units, Pediatric , Meningococcal Infections/diagnosis , Prognosis , Shock/etiology
16.
Pediatr Crit Care Med ; 2(3): 197-204, 2001 Jul.
Article in English | MEDLINE | ID: mdl-12793941

ABSTRACT

OBJECTIVE: To present a review of current knowledge of the use of mechanical ventilatory support in the management of infants with respiratory failure secondary to infection with respiratory syncytial virus (RSV). DATA SOURCES: MEDLINE and manual search for case reports and clinical trials that address management strategies for respiratory support of infants with RSV infection. Data Extraction and Synthesis: Critical appraisal of reported epidemiologic and clinical data regarding risk factors, pathophysiology, and efficacy of respiratory therapy. There is an increasing number of hospital admissions for RSV infection with a variable proportion of infants who need mechanical ventilatory support. The mortality rate is estimated to be <1% in infants without preexisting respiratory or cardiac disorders vs. <5% in those with preexisting respiratory or cardiac disorders. Optimal ventilator settings need to be refined according to the dominant obstructive or restrictive pattern with the aim to avoid barovolutrauma. The role of noninvasive ventilation and additional therapies (heliox, beta(2) agonists, surfactant) is not conclusively established. The indications for high-frequency oscillatory ventilation with the possible adjunction of inhaled nitric oxide deserve further study. Extracorporeal membrane oxygenation plays a minor role in severe cases that are refractory to conventional treatment. CONCLUSIONS: Conventional ventilation strategies are usually adequate for treating infants with severe RSV infection. Particular attention must be paid to the dominant pathophysiologic mechanism in a given condition. Prospective trials are needed to validate alternative therapeutic options and to improve the outcome of the rare but most severe cases that are difficult to control.

17.
Am J Respir Crit Care Med ; 162(1): 139-47, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10903233

ABSTRACT

We applied to 20 paralyzed ventilated children (0.15 to 14.3 yr, six with acute respiratory distress syndrome [ARDS]) the low-flow inflation (LFI) technique providing quasi-static volume-pressure (V-P) curves and compared the assessment of overdistension (OD) on dynamic and LFI (reference) inspiratory V-P curves. Dynamic curves were obtained at the airway opening during regular constant flow ventilation (Servo 300). Then LFI curves were obtained. Two analyses were performed: First, the nonlinear coefficient c of a second order polynomial equation (SOPE) fitted to dynamic data obtained during constant flow was compared with the c of SOPE fitted to LFI curve (within tidal volume [VT]). Second, the dynamic C20/C (ratio of compliance of the last 20% of the curve (C20) to total compliance [C]) was compared with the determination of the upper inflection point (UIP) on the LFI curve. OD was defined as a negative value of c, a C20/C < 0.80, an UIP included within the VT range for that child during regular ventilation. Using LFI V-P curves as reference, SOPE offered a better detection of OD than dynamic C20/C or the determination of the UIP by graphical means. Indeed the first analysis showed a substantial agreement (kappa 0.75) between dynamic c and LFI c detection of OD whereas the second analysis showed a poor agreement (kappa 0.22) between C20/ C and LFI detection of the UIP. In conclusion, quasi-static V-P curves can easily be obtained in children with the LFI technique. SOPE offers a good detection of OD on dynamic and LFI V-P curves but the C20/C index seems to be an inadequate measure of OD.


Subject(s)
Respiration, Artificial , Adolescent , Child , Child, Preschool , Female , Humans , Infant , Male , Maximal Expiratory Flow-Volume Curves , Respiration, Artificial/methods
18.
Arch Pediatr ; 7 Suppl 1: 14S-20S, 2000 Mar.
Article in French | MEDLINE | ID: mdl-10793942

ABSTRACT

Upper airway obstruction is a frequent cause of admission to the emergency department and the intensive care unit. Symptoms are mainly represented by dyspnea and stridor. Severity must be rapidly assessed to allow adapted treatment and avoid cardiac arrest and hypoxic encephalopathy. The possible etiologies are numerous, with acquired and congenital ones, but the majority is represented by laryngitis, lymphoid hypertrophy and laryngotracheomalacia. In case of respiratory failure, treatment must first establish airway patency with bag and mask ventilation, and then intubation. If vital prognosis is not threatened, biologic, radiologic or endoscopic examination can be performed to identify the cause of the obstruction and treat it.


Subject(s)
Airway Obstruction , Age Factors , Airway Obstruction/diagnosis , Airway Obstruction/etiology , Airway Obstruction/therapy , Child , Child, Preschool , Craniofacial Abnormalities/complications , Diagnosis, Differential , Epiglottitis/complications , Epiglottitis/diagnosis , Humans , Infant , Laryngeal Diseases/complications , Laryngitis/complications , Laryngitis/diagnosis , Prognosis , Respiratory Sounds , Tracheal Diseases/complications
SELECTION OF CITATIONS
SEARCH DETAIL
...